Scientech Research LLC’s Bristol-Myers Squibb BMY Stock Holding History

Scientech Research LLC’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,110	Closed	-$572K	–	585
2024 Q4	$572K	Buy	+10,110	New	+$565K	0.16%	249
2024 Q3	–	Sell	-30,081	Closed	-$1.25M	–	629
2024 Q2	$1.25M	Buy	+30,081	New	+$1.35M	0.26%	133
2024 Q1	–	Sell	-4,393	Closed	-$225K	–	426
2023 Q4	$225K	Buy	+4,393	New	+$231K	0.22%	215

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Scientech Research LLC's BMY Position: Q1 2025 in Review

Scientech Research LLC sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 10,110 shares — an estimated $572K sold.

Scientech Research LLC first reported a position in BMY in Q4 2023 and held it in 3 quarters. The position peaked at $1.25M in Q2 2024. 2,485 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

Scientech Research LLC reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
Scientech Research LLC sold 10,110 Bristol-Myers Squibb shares in Q1 2025, an estimated $572K.
Scientech Research LLC first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 3 quarters.
Scientech Research LLC's Bristol-Myers Squibb position peaked at $1.25M in Q2 2024.
2,485 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Scientech Research LLC's 13F filing for Q1 2025, filed 15 May 2025.